The in vitro effect of macrolides on the interaction of human polymorphonuclear leukocytes with Pseudomonas aeruginosa in biofilm

被引:33
|
作者
Takeoka, K [1 ]
Ichimiya, T [1 ]
Yamasaki, T [1 ]
Nasu, M [1 ]
机构
[1] Oita Med Univ, Dept Internal Med 2, Oita 87955, Japan
关键词
macrolides; Pseudomonas aeruginosa; biofilm; polymorphonuclear leukocytes; chemiluminescence;
D O I
10.1159/000007114
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The in vitro effect of macrolides at concentrations below the minimum inhibitory concentration (sub-MIC) on the interaction between Pseudomonas aeruginosa biofilm and human polymorphonuclear leukocytes (PMNs) was investigated by using a chemiluminescence assay. The PMN response to either mucoid or nonmucoid P. aeruginosa biofilm was strongly reduced compared with the response to planktonic bacteria (p < 0.01, p < 0.001, respectively). When biofilms were treated with erythromycin, clarithromycin, roxithromycin and azithromycin prior to incubation with PMNs, the chemiluminescence response was markedly enhanced as compared to untreated controls, and a dose-dependent effect was noted over the range of sub-MIG concentrations studied. In general, macrolides appeared to be slightly more active against mucoid biofilm. Azithromycin was shown to be the most active macrolide against P. aeruginosa biofilms. However, the treatment with sub-MICs of rokitamycin did not have any effect. On the other hand, treatment of planktonic bacteria with macrolides before being exposed to the PMNs did not affect the chemiluminescence response as compared to untreated controls. These findings suggest that macrolides inhibiting the biofilm formation of P. aeruginosa may facilitate the phagocytosis of bacteria by PMNs.
引用
收藏
页码:190 / 197
页数:8
相关论文
共 50 条
  • [21] The Inhibitory Effect of Chlorogenic Acid on Biofilm of Pseudomonas Aeruginosa in Vitro
    Wen, H. X.
    Sun, L.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2014, 62 : S380 - S380
  • [22] Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes
    Alhede, Morten
    Bjarnsholt, Thomas
    Jensen, Peter O.
    Phipps, Richard Kerry
    Moser, Claus
    Christophersen, Lars
    Christensen, Louise Dahl
    van Gennip, Maria
    Parsek, Matt
    Hoiby, Niels
    Rasmussen, Thomas Bovbjerg
    Givskov, Michael
    MICROBIOLOGY-SGM, 2009, 155 : 3500 - 3508
  • [23] EFFECT OF CEFTRIAXONE ON PSEUDOMONAS-AERUGINOSA AND STAPHYLOCOCCUS-AUREUS IN BROTH, SERUM, AND IN COMBINATION WITH HUMAN POLYMORPHONUCLEAR LEUKOCYTES
    BASSLER, M
    BLASCHKE, H
    JUST, M
    DASCHNER, FD
    CHEMOTHERAPY, 1982, 28 (05) : 390 - 396
  • [24] Effects of Combined Treatment with Sansanmycin and Macrolides on Pseudomonas aeruginosa and Formation of Biofilm
    YUE LI*
    #Department of Microbiology and Biochemical Pharmacy
    Biomedical and Environmental Sciences, 2009, 22 (02) : 170 - 177
  • [25] Effects of Combined Treatment with Sansanmycin and Macrolides on Pseudomonas aeruginosa and Formation of Biofilm
    Li, Yue
    Xie, Yun-Ying
    Chen, Ru-Xian
    Xu, Hong-Zhang
    Zhang, Guo-Ji
    Li, Jin-Zhe
    Li, Xiao-Mian
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2009, 22 (02) : 170 - 177
  • [26] PHYSIOLOGICAL-EFFECTS OF A BACTERICIDAL PROTEIN FROM HUMAN POLYMORPHONUCLEAR LEUKOCYTES ON PSEUDOMONAS-AERUGINOSA
    HOVDE, CJ
    GRAY, BH
    INFECTION AND IMMUNITY, 1986, 52 (01) : 90 - 95
  • [28] The role of proteinases from Pseudomonas aeruginosa and polymorphonuclear leukocytes in cystic fibrosis
    Doring, G
    DRUGS OF TODAY, 1997, 33 (06): : 393 - 403
  • [29] In vitro and in silico evaluation of the serrapeptase effect on biofilm and amyloids of Pseudomonas aeruginosa
    Georgios Katsipis
    Dimitrios I. Avgoulas
    George D. Geromichalos
    Maria Petala
    Anastasia A. Pantazaki
    Applied Microbiology and Biotechnology, 2023, 107 : 7269 - 7285
  • [30] PHAGOCYTOSIS OF PSEUDOMONAS-AERUGINOSA BY POLYMORPHONUCLEAR LEUKOCYTES AND MONOCYTES - EFFECT OF CYSTIC-FIBROSIS SERUM
    THOMASSEN, MJ
    DEMKO, CA
    WOOD, RE
    SHERMAN, JM
    INFECTION AND IMMUNITY, 1982, 38 (02) : 802 - 805